Skip to main content
Equibles
GKOS logo

GKOS · GLAUKOS Corp · Metrics

Track GKOS — free

Use GKOS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GKOS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$237.60 -4.88 (-2.01%) At close · Oct 30 Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$14.07B
Shares
59.20M
Volume · Oct 30 2.07M Avg daily vol (3M) 950.53K

GKOS metrics

91 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$237.60
Market cap
$14.07B

Price action

20 metrics
Price change (1W)
+32.8%
Price change (30D)
+45.6%
Price change (3M)
+42.5%
Price change (6M)
+69.4%
Price change (YTD)
+110.4%
Price change (1Y)
+170.6%
Trailing year
Price change (5Y)
+419.8%
52-week high
$242.48
52-week low
$81.79
Change from 52-week high
-2.0%
Change from 52-week low
+190.5%
Annualized volatility
60.0%
Annualized volatility (3M)
75.5%
Beta
0.9
RSI (14D)
82.6
Price vs SMA 50
+37.1%
Price vs SMA 200
+68.0%
Avg volume (3M)
950,528
Relative volume
2.2
Average dollar volume
$171.17M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
59.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
20.2×
reciprocal yield 4.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
20.4×
reciprocal yield 4.9%
P / book
19.6
reciprocal yield 5.1%
FCF yield
0.3%
TTM · current market cap
Buyback yield
—
P / FCF
390.5
reciprocal yield 0.3%
P / operating cash flow
294.8
reciprocal yield 0.3%
Earnings yield
-1.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
14.9×
reciprocal yield 6.7%
EV / revenue historical average (5Y)
12.9×
reciprocal yield 7.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
64.8%
Operating margin
-25.5%
Trailing 12 months
Net margin
-24.6%
Gross profit (TTM)
$447.18M
Operating profit (TTM)
−$176.16M
Net income (TTM)
−$169.80M
Trailing 12 months
Diluted EPS (TTM)
$-2.96
FCF margin
5.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$11.69
Gross profit per diluted share (TTM)
$7.51
Operating profit per diluted share (TTM)
$-3.05
EBITDA per diluted share (TTM)
$-2.34
Net income per diluted share (TTM)
$-2.94
Operating cash flow per diluted share (TTM)
$0.79
Free cash flow per diluted share (TTM)
$0.59
Capital expenditures per diluted share (TTM)
$0.20
R&D per diluted share (TTM)
$3.09
Stock compensation per diluted share (TTM)
$1.41
Book value per share
$11.41

Growth

11 metrics
Revenue growth YoY
+58.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$690.33M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+6.6%
Year over year · more shares
Revenue CAGR (3Y)
+21.5%
Revenue CAGR (5Y)
+17.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-23.7%
Return on assets
-17.3%
Debt / equity
0.1
Current ratio
4.6
EBITDA (TTM)
−$134.38M
Free cash flow (TTM)
$36.02M
Quick ratio
4.1
Interest coverage
-36.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$95.40M
Latest balance sheet
Cash & equivalents
$162.33M
Total assets
$979.53M
Total debt
$66.93M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$47.71M
Capital expenditures (TTM)
$11.69M
R&D (TTM)
$181.26M
SG&A (TTM)
$434.65M
Stock compensation (TTM)
$83.08M
R&D / revenue
26.3%
Stock compensation / revenue
12.0%

Ownership (13F)

9 metrics
13F filers
369
13F filer change QoQ
+27
Institutional ownership
104.3%
Conviction holders (share of 13F filers)
0.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+5.5%
Holder tenure
12.9
Price vs estimated holder cost
+25.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.6%

Short interest

3 metrics
Short interest
7.3%
Latest settlement · 4.0 days to cover
Days to cover
4.0d
Short-squeeze score
95 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$18.09M
Insider-sentiment score
12 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1192448 CUSIP 377322102 13F (30d) 125 filings 111 filers Visit website Investor relations